VICTOR ESTUPINAN: Open Payments
NPI 1699559351 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 18 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $783 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $194 |
| Janssen Pharmaceuticals, Inc | 2 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Validus Pharmaceuticals LLC | 1 | $24 |
| Almatica Pharma LLC | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: VRAYLAR, INVEGA SUSTENNA, CAPLYTA, FANAPT, EQUETRO, LOREEV XR, Auvelity.
Industry payments across TX — which companies pay providers there.
